SCHEMBL5362483

SCHEMBL5362483

Cc1ccccc1C(F)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.43
TSHR P16473 1/20 0.43
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
HSD11B1 P28845 2/20 0.35
PDK2 Q15119 2/20 0.35
PDK1 Q15118 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
ALDH1A1 P00352 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
TRPA1 O75762 2/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
NR3C1 P04150 2/20 0.33
NR3C2 P08235 2/20 0.33
TDP1 Q9NUW8 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5358414 0.81 TRPA1 (0.44) ACHETSHRGABRA1GABRB2PDK2
SCHEMBL3277341 0.80 ACHE (0.43) ACHETSHRGABRA1GABRB2HSD11B1
SCHEMBL16105712 0.80 ACHE (0.43) ACHETSHRGABRA1GABRB2HSD11B1
SCHEMBL11623026 0.79 ACHE (0.47) ACHETSHRGABRA1GABRB2HSD11B1
SCHEMBL169124 0.79 TSHR (0.47) ACHETSHRGABRA1GABRB2HSD11B1
SCHEMBL29656610 0.79 TSHR (0.47) ACHETSHRGABRA1GABRB2HSD11B1
SCHEMBL13324333 0.78 ACHE (0.41) ACHETSHRGABRA1GABRB2HSD11B1
SCHEMBL5958679 0.78 CD44 (0.46) ACHETSHRGABRA1GABRB2PDK2
Ammonia Solution, Strong SCHEMBL1870627 0.77 HSD11B1 (0.45) ACHETSHRGABRA1GABRB2HSD11B1
SCHEMBL10034988 0.77 ACHE (0.45) ACHETSHRGABRA1GABRB2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104803826-B A kind of method utilizing hexafluoropropene that aryl boric acid directly aoxidizes seven fluorine isopropylations 中国科学院上海有机化学研究所 2016-08-17 CN disclosed
CN-104803826-A Method for directly oxidizing arylboronic acid into heptafluoroisopropyl by utilizing hexafluoropropylene SHANGHAI INST ORGANIC CHEM 2015-07-29 CN disclosed
US-7169955-B2 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2007-01-30 US disclosed
US-20050113567-A1 Perfluoroisopropylbenzene derivative NIHON NOHYAKU CO., LTD. (JP) 2005-05-26 US disclosed
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE NIHON NOHYAKU CO., LTD. (JP) 2003-10-02 US disclosed
EP-1253128-A1 PERFLUOROISOPROPYLBENZENE DERIVATIVES Nihon Nohyaku Co., Ltd. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187233-A1 PERFLUOROISOPROPYBENZENE DERIVATIVE AFF1, CBR1, RER1 ACHE 3978/4885TSHR 232/4885GABRA1 1819/4885
US-20050113567-A1 Perfluoroisopropylbenzene derivative FFAR3, CBR3, HCAR3 ACHE 3516/4885TSHR 60/4885GABRA1 874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.